Clinical trial
Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast…
NCT00002937 · City of Hope Medical Center, Other · Completed
Key facts
| NCT number | NCT00002937 |
|---|---|
| Title | Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer |
| Official title | A Phase II Randomized Study of Paclitaxel Versus Paclitaxel + PSC833 for Advanced Breast Cancer (Recurring Less Than 6 Months Since Adjuvant or as Second Line for Advanced Disease |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel, valspodar |
| Enrollment | 70 |
| Start date | Jun 1, 1996 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 3, 2004 |
| Last update posted | Jan 6, 2010 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: